medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2023, Number 4

<< Back Next >>

Acta Med 2023; 21 (4)

Incidence of contrast-associated renal injury in the hemodynamics ward: a retrospective study

Sagarnaga QE, Lugo BKS, Taracena PS, Cabrera PD, Cabrera JR, Rodríguez WFL, Díaz GEJ

Language: Spanish
References: 30
Page: 333-337
PDF size: 174.31 Kb.


ABSTRACT

Introduction: the use of diagnostic-therapeutic procedures that involve the administration of intravenous contrast is increasingly common; it is known that contrast-induced nephropathy is a possible complication. The incidence in the literature ranges from 0.5-5% in healthy patients and 12-27% in patients with previous kidney disease. Objective: to identify the incidence of this complication in our environment and the characteristics associated with its presentation. Material and methods: patients who underwent procedures involving the administration of IV contrast in the catheterization laboratory of the Hospital Angeles Pedregal in the period of 2019-2020 were studied. Laboratory studies were reviewed, and hospital courses and outcomes. Results: contrast-induced nephropathy was present in 11 patients out of a total of 202 (5.44%); the main predisposing factors were the presence of previous kidney disease, comorbidities, general physical status, and cardiogenic shock development. Conclusions: a lower incidence was found than that reported in the literature. No increased mortality or renal replacement therapy (RRT) requirement was found.


REFERENCES

  1. Ferreira Morales JL. Actualidad en nefropatía por medio de contraste. Nefrol Latinoam. 2017; 14 (2): 69-78.

  2. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994; 331 (21): 1449-1450.

  3. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120 (4): c179-c184.

  4. Meinel FG, De Cecco CN, Schoepf UJ, Katzberg R. Contrast-induced acute kidney injury: definition, epidemiology, and outcome. Biomed Res Int. 2014; 2014: 859328.

  5. Mohammed NMA, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart Views. 2013; 14: 106-116.

  6. López-López B, Pérez-López MJ, García-Rincón A, Vázquez-Vega B. Evolución de nefropatía por contraste en pacientes con enfermedad renal crónica sometidos a intervención coronaria percutánea. Rev Med Inst Mex Seguro Soc. 2015; 53 (4): 484-488.

  7. Cho JY, Jeong MH, Hwan Park S, Kim IS, Park KH, Sim DS et al. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure. J Cardiol. 2010; 56 (3): 300-306.

  8. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ; nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348 (6): 491-499.

  9. Osorio Valero M. Nefropatía inducida por medio de contraste endovenoso yodado. Anales de Radiología México. 2011; 1: 21-26.

  10. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172 (11): 1461-1471.

  11. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998; 32 (7): 1861-1865.

  12. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology. 2010; 256 (1): 21-28.

  13. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008; 191 (2): 376-382.

  14. Aguirre Caicedo M. Nefropatía por medios de contraste. Acta Médica Colombiana. 2007; 32 (2): 68-79.

  15. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol. 1995; 6 (5): 1451-1458.

  16. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016; 102 (8): 638-648.

  17. García-Hernández R, Hernández-Navas M, Aroche-Aportela R, Obregón-Santos A. Nefropatía inducida por contraste. CorSalud. 2016; 8 (2): 117-124.

  18. Itoh Y, Yano T, Sendo T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci. 2005; 97 (4): 473-488.

  19. Fernández-Cimadevilla OC, Barriales-Alvarez V, Lozano-Martínez Luengas I. Nefropatía inducida por contraste. Med Clin (Barc). 2011; 137 (2): 84-86.

  20. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990; 258 (1 Pt 2): F115-F120.

  21. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006; 354 (4): 379-386.

  22. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105 (19): 2259-2264.

  23. Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr. Contrast nephropathy : an evidence-based approach to prevention. Am J Cardiovasc Drugs. 2003; 3 (6): 395-405.

  24. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation. 2012; 125 (25): 3099-3107.

  25. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005; 21 (2): 261-280.

  26. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47 (1): 254-261.

  27. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996; 275 (19): 1489-1494.

  28. James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013; 6 (1): 37-43.

  29. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol. 2006; 17 (10): 2871-2877.

  30. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000; 36 (5): 1542-1548.




2020     |     www.medigraphic.com